Cardiovascular/Renal Drugs EC Flashcards
Drugs to treat Essential Hypertension
Diuretics
ACE inhibitors
ARBs
Ca channel blockers
Drugs to treat CHF
Diuretics ACE inhibitors ARBs Beta-blockers (compensated CHF only) K-sparing diuretics
DM hypertension treatment
ACE inhibitors ARBs Ca channel blockers Diuretics Beta-blockers Alpha blockers
Nifedipine, Amlodipine, Verapamil, Diltiazem (MOA, Use, Tox)
Block voltage gated L-type Ca channels (reduce contractility in cardiac and smooth muscle)
Amlodipine and Nifedipine esp in Smooth Muscle
Verapamil and Diltiazem esp in Heart
Cardiac depression
AV block
Peripheral edema
Hydralazine (MOA, Use, Tox)
Increase cGMP = vasodilates arterioles
Severe hypertension
CHF
First line for HTN in pregnancy (w/ methyldopa)
Compensatory tachycardia (given w/ beta blocker to prevent - contra. in CAD)
Fluid retention
Lupus-like syndrome
Malignant hypertension treatment (Drugs, Use, Tox)
Nitroprusside (increase cGMP via NO release)
~can cause cyanide toxicity
Fenoldopam (D1 agonist - Lower BP and increased natriuresis)
Nitroglycerin, Isosorbide, Dinitrate (MOA, Use, Tox)
Increase cGMP via NO release
Dilates VEINS
Angina
Pulmonary edema
Reflex tachycardia
Hypotension
“Monday disease” (tolerance during week, loss of tolerance over weekend results in tachycardia, dizziness, and headache in new week)
Lovastatin, Pravastatin, Simvastatin, Atorvastatin, Rosuvastatin (MOA, Effects, Tox)
Block formation of mevalonate by inhibiting HMG-CoA reductase (results in UPREGULATION OF LDLR)
LDL=big decrease, HLD=mild increase, TG=mild decrease
Hepatotoxicity
Rhabdomyolysis
Niacin (vit. B3) (MOA, Use, Tox)
Inhibits lipolysis in adipose; reduces hepatic VLDL secretion into circulation
LDL=decrease, HDL=Increased, TG=mild decrease
Flushed face (decreased by aspirin or long term use)
Hyperglycemia
Hyperuricemia
Cholestyramine, Colestipol, Colesevelam (MOA, Use, Tox)
Prevent intestinal reabsorption of bile (results in UPREGULATION OF LDLR)
LDL=decrease, HDL=slight increase, TG=slight increase
Terrible taste
GI discomfort
Decrease fat soluble vitamin absorption
Cholesterol gallstones
Ezetimibe (MOA, Use, Tox)
Prevents cholesterol reabsorption at brush border
LDL=decrease
Hepatotoxicity
Diarrhea
Gemfibrozil, Clofibrate, Bezafibrate, Fenofibrate (MOA, Use, Tox)
Upregulate LPL (INCREASED TG CLEARANCE)
LDL=minor decrease, HDL=minor increase, TG=BIG decrease
Myositis
Hepatotoxicity
Cholesterol gallstones
Digoxin (MOA, Use, Tox, Contraindications/Antidote)
Na/K pump inhibition leads to inhibition of Na/Ca exchange and INCREASED INTRACELLULAR Ca (inotropy)
CHF
A-fib (decreased conduction at AV node and depression of SA node)
Cholinergic
ECG - Increase PR, decrease QT, ST scooping, T-wave inversion, Arrhythmia, AV block
Hyperkalemia
Contraindications:
Renal failure (renally excreted)
Hypokalemia (too much digoxin binding)
Quinidine (displaces from binding sites and and decrease clearance)
Antidotes: Slowly normalize K, Lidocaine, Cardiac pacer,
ANTI-DIGOXIN FAB FRAGMENTS, Mg
Antiarrhythmic Drug Classes
“No Bad-Boy Keeps Clean”
Na channel blockers
Beta-Blocker
K channel blockers
Ca channel blockers
Class I Antiarrhythmic Drugs and Class
“Double Quarter Pounder
Lettuce Tomatoes Mayo
Fries Please”
Disopyramide, Quinidine, Procainamide (IA)
Lidocaine, Tocainide, Mexiletine (IB)
Flecainide, Propafenone (IC)